Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Cited by 6 publications
References 28 publications
Bovine mastitis remains a major prevalent disease in cattle and places a significant economic burden on the global dairy industry. The goal of this systematic review and meta-analysis was to examine the overall prevalence of mastitis and its associated risk factors among dairy cows. Scientific articles written in English were recovered from PubMed, ScienceDirect, Web of Science, Google Scholar, Cochrane Library, and other sources from Google Engine and University Library Databases. “Prevalence,” “bovine mastitis,” “clinical mastitis,” “subclinical mastitis,” “associated factors,” “dairy cows,” and “Ethiopia” were search terms used for this study. For critical appraisal, PRISMA 2009 was applied. Heterogeneity and publication bias were evaluated using Cochran's Q , inverse variance ( I 2 ), and funnel plot asymmetry tests. A random-effects model was used to calculate the pooled burden of mastitis and its associated factors among dairy cows, along with the parallel odds ratio (OR) and 95% confidence interval (CI). A total of 6438 dairy cows were included in the 17 eligible studies for this meta-analysis. The overall pooled prevalence of mastitis among dairy cows in Ethiopia was 43.60% (95% CI: 34.71, 52.49), of which 12.59% (95% CI: 7.18, 18.00) and 32.21% (95% CI: 24.68, 39.74) were clinical and subclinical cases, respectively. Of the regions, the highest and lowest pooled prevalence estimates of mastitis among dairy cows were 49.90% (95% CI: 31.77, 68.03) and 25.09% (95% CI: 3.86, 46.32) in the Oromia and Amhara regions, respectively. The highest pooled prevalence estimate in the study period was recorded between 2017 and 2022, with a pooled prevalence estimate of 46.83% (95% CI: 35.68, 57.97), followed by the study period from 2005 to 2016, with a pooled prevalence estimate of 39.97% (95% CI: 25.50, 54.44). Gram-positive bacteria (84.70%) were the most prevalent mastitis-causing agents compared with Gram-negative bacteria (15.30%). Breed (AOR: 2.17, 95% CI: 1.44, 2.90), lactation stage (AOR: 1.59, 95% CI: 1.04, 2.15), parity (AOR: 3.31, 95% CI: 1.69, 4.94), history of mastitis (AOR: 3.56, 95% CI: 2.40, 4.71), floor type (AOR: 1.59, 95% CI: −0.16, 3.34), and teat injury (AOR: 6.98, 95% CI: 0.33, 13.64) were factors significantly associated with mastitis among dairy cows in Ethiopia. Early diagnosis and proper medication, as well as implementing appropriate prevention and control measures, are necessary for the management of mastitis in dairy cows.
Bovine mastitis remains a major prevalent disease in cattle and places a significant economic burden on the global dairy industry. The goal of this systematic review and meta-analysis was to examine the overall prevalence of mastitis and its associated risk factors among dairy cows. Scientific articles written in English were recovered from PubMed, ScienceDirect, Web of Science, Google Scholar, Cochrane Library, and other sources from Google Engine and University Library Databases. “Prevalence,” “bovine mastitis,” “clinical mastitis,” “subclinical mastitis,” “associated factors,” “dairy cows,” and “Ethiopia” were search terms used for this study. For critical appraisal, PRISMA 2009 was applied. Heterogeneity and publication bias were evaluated using Cochran's Q , inverse variance ( I 2 ), and funnel plot asymmetry tests. A random-effects model was used to calculate the pooled burden of mastitis and its associated factors among dairy cows, along with the parallel odds ratio (OR) and 95% confidence interval (CI). A total of 6438 dairy cows were included in the 17 eligible studies for this meta-analysis. The overall pooled prevalence of mastitis among dairy cows in Ethiopia was 43.60% (95% CI: 34.71, 52.49), of which 12.59% (95% CI: 7.18, 18.00) and 32.21% (95% CI: 24.68, 39.74) were clinical and subclinical cases, respectively. Of the regions, the highest and lowest pooled prevalence estimates of mastitis among dairy cows were 49.90% (95% CI: 31.77, 68.03) and 25.09% (95% CI: 3.86, 46.32) in the Oromia and Amhara regions, respectively. The highest pooled prevalence estimate in the study period was recorded between 2017 and 2022, with a pooled prevalence estimate of 46.83% (95% CI: 35.68, 57.97), followed by the study period from 2005 to 2016, with a pooled prevalence estimate of 39.97% (95% CI: 25.50, 54.44). Gram-positive bacteria (84.70%) were the most prevalent mastitis-causing agents compared with Gram-negative bacteria (15.30%). Breed (AOR: 2.17, 95% CI: 1.44, 2.90), lactation stage (AOR: 1.59, 95% CI: 1.04, 2.15), parity (AOR: 3.31, 95% CI: 1.69, 4.94), history of mastitis (AOR: 3.56, 95% CI: 2.40, 4.71), floor type (AOR: 1.59, 95% CI: −0.16, 3.34), and teat injury (AOR: 6.98, 95% CI: 0.33, 13.64) were factors significantly associated with mastitis among dairy cows in Ethiopia. Early diagnosis and proper medication, as well as implementing appropriate prevention and control measures, are necessary for the management of mastitis in dairy cows.
Isolation and identification of bacteria causing mastitis in small ruminants and their susceptibility to antibiotics, honey, essential oils, and plant extracts
Aim:The present work aims to isolate and identify bacteria that cause mastitis in small ruminants and evaluates the antibacterial activity of some antibiotics, honey, essential oils, and plant extracts.Materials and Methods:A total of 289 milk samples were collected from udder secretions of sheep (n=189) and goat (n=100) from El-Fayoum, Beni-Suef, and Giza governorates. Screening subclinical mastitis (SCM) was done using California Mastitis Test (CMT); identification of the isolates was achieved using Gram’s staining, hemolytic pattern, colony morphology, and biochemical tests using Analytical Profile Index.Results:On clinical examination, the incidence of clinical mastitis (CM) was found to be 5.88% and 7% in sheep and goat, respectively. On CMT, SCM was found to be 25 (13.23%) and 11 (10%) in sheep and goat, respectively. Bacteriological examination of all milk samples found the presence of Staphylococcus aureus (SA) (31.1%), coagulase-negative staphylococci (CNS) (19.5%), Escherichia coli (EC) (8.3%), Streptococcus spp. (5.6%), Klebsiella spp. (3.77%), and Pseudomonas spp. (1.89%), while no bacteria were cultured from 81.66% of the samples. Identification of 9 isolates of CNS was achieved by using API staph test to Staphylococcus epidermidis, Staphylococcus hominis, Staphylococcus cohnii, and Staphylococcus saprophyticus. The highest bacterial resistance was found in EC (67.14%) followed by Kp (45.28%) and SA (26.57%).Conclusion:Onion and black cumin essential oils followed by Egyptian honey showed strong antibacterial effects against multidrug-resistant bacteria. Finally, our study proved that Egyptian honey, onion, and black cumin essential oils have a marked strong antibacterial effect against bacteria isolated from small ruminant mastitis, but still further extensive studies are needed to discover the therapeutic properties of these plant extracts and honey.
Aim: This study aimed to estimate the prevalence and clinical presentations of different forms of mastitis and mastitis-causing pathogens in lactating goats in Bauchi, Plateau, and Edo states, Nigeria. Materials and Methods: A total of 500 quarters from 250 lactating goats of Red Sokoto and West African Dwarf breeds during the lactation period were clinically examined. Clinical mastitis was detected by gross signs of udder infection during physical examination and abnormal milk, whereas subclinical mastitis (SCM) was recognized using California mastitis test. The bacterial pathogens were identified by morphology, hemolysis, gram staining, and biochemical tests such as catalase, oxidase, coagulase, reaction on sulfite, indole, and motile medium, and fermentation of sugars. Results: The overall prevalence of mastitis in goats was found to be 101 (40.4%), of which 8% (20/250) were clinical, and 32.4% (81/250) were SCM cases. The quarter level prevalence was 29.4% (145/493), comprising 5.9% (29/493) clinical and 23.2% (116/493) subclinical forms of mastitis. In addition, 1.4% (7/500) of teats were found to be blind on the clinical examination of the udder and teat. Several regional inflammatory reactions and abnormalities in milk were found in 69% and 100% of the cases, respectively. Moreover, some indications of generalized signs such as fever, reduction in appetite, increase in respiration, and pulse rate per minute were recorded in 100%, 75%, 85% and 80% of the cases, respectively. The predominant bacterial isolates recovered were Staphylococcus aureus (20.0%), followed by Escherichia coli (15.5%) and Streptococcus agalactiae (11.0%), and the least isolated microorganisms (≤6%) were bacteria of different species including Staphylococcus auricularis, Staphylococcus caprae, Staphylococcus chromogenes, Staphylococcus epidermidis, Staphylococcus hyicus, Staphylococcus xylosus, Staphylococcus lentus, Streptococcus dysgalactiae, Streptococcus pluranimalium, Streptococcus uberis, Streptococcus pneumoniae, Streptococcus ruminatorum, Streptococcus suis, Micrococcus luteus, Enterobacter cloacae, Proteus vulgaris, Klebsiella oxytoca, Klebsiella pneumoniae, Morganella morganii, Salmonella Typhimurium, Citrobacter freundii, Pseudomonas aeruginosa, Acinetobacter rudis, Acinetobacter haemolyticus, and Bacillus cereus. Conclusion: Mastitis continues to be recognized as one of the important health issues and leads to major economic losses to the dairy goats caused by many bacterial pathogens, and the effective measures need to be taken to control the disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Contact Info
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Product
Resources
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.
